{"id":"https://openalex.org/W2941458862","doi":null,"title":"Evolving Use of ICIs and Targeted Tx in NSCLC and SCLC","display_name":"Evolving Use of ICIs and Targeted Tx in NSCLC and SCLC","publication_year":2018,"publication_date":"2018-06-08","ids":{"openalex":"https://openalex.org/W2941458862","mag":"2941458862"},"language":"en","primary_location":{"id":"mag:2941458862","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/asco-street-team/evolving-use-icis-and-targeted-tx-nsclc-and-sclc","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024497224","display_name":"Apar Kishor Ganti","orcid":"https://orcid.org/0000-0003-3724-2671","observed_orcids":["https://orcid.org/0000-0003-3724-2671"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Apar Kishor Ganti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3724-2671","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5024497224"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27981162,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6820999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6820999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2727000117301941,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.890999972820282},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/lung-cancer-treatment","display_name":"lung cancer treatment","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3819631338119507},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.34359806776046753}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2941458862","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/asco-street-team/evolving-use-icis-and-targeted-tx-nsclc-and-sclc","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6941292864","https://openalex.org/W2904327650","https://openalex.org/W2946451503","https://openalex.org/W3012566948","https://openalex.org/W2331691994","https://openalex.org/W6960178452","https://openalex.org/W6941346918","https://openalex.org/W4407578632","https://openalex.org/W2945954150","https://openalex.org/W2990680987"],"abstract_inverted_index":{"In":[0],"this":[1],"video,":[2],"Apar":[3],"Ganti,":[4],"MD,":[5],"highlights":[6],"recent":[7],"advances":[8],"and":[9,19,23],"studies":[10],"presented":[11],"at":[12],"ASCO":[13],"2018":[14],"on":[15],"management":[16],"of":[17],"NSCLC":[18],"SCLC":[20],"with":[21],"ICIs":[22],"targeted":[24],"agents.":[25]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-03T00:00:00"}